XML 53 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Jan. 03, 2025
Share-Based Payment Arrangement [Abstract]  
Share-Based Compensation, Restricted Stock Units Award Activity

The number of unvested restricted stock unit awards outstanding as of January 3, 2025 is as follows (1):

 

 

Number
of awards
outstanding

 

 

Weighted-
average
grant date
fair value

 

 

Weighted-
average
remaining
contractual
term (years)

 

 

Aggregate
intrinsic value
(in thousands)
(2)

 

Balance at December 29, 2023

 

 

418,708

 

 

$

88.78

 

 

 

 

 

 

 

Awards granted

 

 

284,912

 

 

 

79.59

 

 

 

 

 

 

 

Awards vested

 

 

(266,859

)

 

 

74.70

 

 

 

 

 

 

 

Awards forfeited

 

 

(23,465

)

 

 

90.72

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 3, 2025

 

 

413,296

 

 

$

91.43

 

 

 

1.9

 

 

$

36,746

 

 

(1)
Does not include employee stock purchase plans or stock option plans.
(2)
The intrinsic value is calculated as the market value as of the end of the fiscal period. As reported by the NASDAQ Global Select Market, the market value as of January 3, 2025 was $88.91.
Stock Option Activity

Option activity is as follows (1):

 

 

Number
of shares
outstanding

 

 

Weighted-
average
exercise
price

 

 

Weighted-
average
remaining
contractual
term (years)

 

 

Aggregate
intrinsic value
(in thousands)

 

Exercisable at December 29, 2023

 

 

463,235

 

 

$

51.86

 

 

 

 

 

 

 

Options granted

 

 

40,000

 

 

 

75.87

 

 

 

 

 

 

 

Options forfeited and expired

 

 

 

 

 

 

 

 

 

 

 

 

Options exercised

 

 

(124,206

)

 

 

31.37

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at January 3, 2025

 

 

379,029

 

 

$

61.11

 

 

 

4.80

 

 

$

11,267

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at January 3, 2025

 

 

289,446

 

 

$

52.79

 

 

 

3.76

 

 

$

10,726

 

 

(1)
Does not include restricted stock or employee stock purchase plans.
The Assumptions Used to Value Option Grants

The assumptions used to value option grants for 2024, 2023 and 2022 are as follows:

 

 

Stock Option Plan

 

 

 

Fiscal Years

 

 

 

2024

 

 

2023

 

 

2022

 

Expected term (in years)

 

 

5.7

 

 

 

5.8

 

 

 

5.6

 

Risk-free interest rate

 

 

4.26

%

 

 

3.99

%

 

 

1.90

%

Volatility

 

 

30

%

 

 

29

%

 

 

28

%

Dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

 

Stock-Based Compensation Expense Recognized in Consolidated Statements of Income

The amount of stock-based compensation expense and the related income tax benefit recognized in the Company’s consolidated statements of income for 2024, 2023 and 2022 is as follows:

 

 

Fiscal Years

 

(In thousands)

 

2024

 

 

2023

 

 

2022

 

Compensation and related expenses:

 

 

 

 

 

 

 

 

 

Restricted stock units

 

$

21,086

 

 

$

18,542

 

 

$

18,810

 

Stock option grants

 

 

1,423

 

 

 

1,081

 

 

 

835

 

Sub-total

 

 

22,509

 

 

 

19,623

 

 

 

19,645

 

 

 

 

 

 

 

 

 

 

General and administrative expenses:

 

 

 

 

 

 

 

 

 

Restricted stock units

 

 

730

 

 

 

734

 

 

 

719

 

Sub-total

 

 

730

 

 

 

734

 

 

 

719

 

Total stock-based compensation expense

 

$

23,239

 

 

$

20,357

 

 

$

20,364

 

 

 

 

 

 

 

 

 

 

Income tax benefit

 

$

2,793

 

 

$

3,620

 

 

$

5,829